Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Niang, S. D."'
Autor:
Ould Ahmedou Salem, M. S., Lemine, Y. O. M., Deida, J. M., Lemrabott, M. A. O., Ouldabdallahi, M., Ba, M. D. D., Ould Mohamed Salem Boukhary, A., Khairy, M. L. O., Aziz, M. B. A., Ringwald, Pascal, Basco, Leonardo, Niang, S. D., Lebatt, S. M.
Background: In 2006, the Mauritanian Ministry of Health adopted a new therapeutic strategy based on the systematic use of artemisinin-based combination therapy (ACT), artesunate-amodiaquine and artemether-lumefantrine, for the first-and second-line t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______932::95f8c60283076dcde1531c2df67352b0
http://www.documentation.ird.fr/hor/fdi:010063887
http://www.documentation.ird.fr/hor/fdi:010063887
Autor:
Ouldabdallahi, M., Alew, I., Ould Ahmedou Salem, M. S., Ba, D. M., Ould Mohamed Salem Boukhary, A., Ould Khairy, M. L., Aziz, M. B. A., Ringwald, P., Basco, Leonardo, Niang, S. D., Lebatt, S. M.
Background: A regular evaluation of therapeutic efficacy in sentinel sites and a system of surveillance are required to establish treatment guidelines and adapt national anti-malarial drug policy to the rapidly changing epidemiology of drug-resistant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______932::79e0d92f85c6eb57d5ad4e6f142eaf02
http://www.documentation.ird.fr/hor/fdi:010063632
http://www.documentation.ird.fr/hor/fdi:010063632
Autor:
Guiguemdé TR; Centre de Référence de la Chimiorésistance du Paludisme (C.R.C.P.), Centre Muraz., Gbary AR, Ouedraogo JB, Gayibor A, Lamizana L, Maiga AS, Boureima HS, Comlanvi CE, Faye O, Niang SD
Publikováno v:
Annales de la Societe belge de medecine tropicale [Ann Soc Belg Med Trop] 1991 Sep; Vol. 71 (3), pp. 199-207.
